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Abstract  
 
Mineralization of elastic fibers in Pseudoxanthoma elasticum (PXE) has been associated with low 
levels of carboxylated Matrix Gla Protein, most likely as a consequence of reduced vitamin K 
availability. Unexpectedly, vitamin K supplementation does not exert beneficial effects on soft 
connective tissue mineralization in the PXE animal model. In order to understand the effects of 
vitamin K supplementation and in the attempt to interfere with pathways leading to the 
accumulation of calcium and phosphate within PXE mineralized soft connective tissues, we have 
performed in vitro studies on dermal fibroblasts isolated from control subjects and from PXE 
patients. Cells were cultured in standard conditions and in calcifying medium in the presence of 
vitamin K1 and K2 or of levamisole, an alkaline phosphatase inhibitor. Control and PXE fibroblasts 
were characterized by a similar dose-dependent uptake of both vitamin K1 and K2, thus promoting 
in all cell lines a significant increase of total protein carboxylation. Nevertheless, MGP 
carboxylation remained much less in PXE fibroblasts. Interestingly, PXE fibroblasts exhibited a 
significantly higher alkaline phosphatase activity. Consistently, the mineralization process induced 
in vitro by a long-term culture in a calcifying medium appeared unaffected by vitamin K, whereas it 
was abolished by levamisole. 
 
 
Introduction  
 
Pseudoxanthoma elasticum (PXE) is a genetic disorder associated to mutations in the ABCC6 gene 
(Le Saux et al., 2000) and characterized by progressive mineralization of elastic fibers affecting 
skin, eyes and the cardiovascular system (Quaglino et al., 2011). Compared to controls, fibroblasts 
from PXE patients exhibit in vitro and in vivo similar matrix gla protein (MGP) expression, but a 
significant reduction of carboxylated-MGP (cMGP) (Gheduzzi et al., 2007), a well known 
endogenous inhibitor of soft tissue calcification (Schurgers et al, 2008). Furthermore, PXE 
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fibroblasts are characterized by a down-regulation of protein disulfide isomerase (PDI) and an up-
regulation of calumenin (CALU), two proteins of the endoplasmic reticulum that are involved in the 
vitamin K cycle (Boraldi et al, 2009). Vitamin K is a group of fat soluble vitamins that, in their 
reduced form, are needed for the posttranslational γ-carboxylation of glutamic acid (gla) residues in 
proteins involved in blood coagulation as well as in the mineralization process (Booth, 2009). 
Interestingly, the low vitamin K concentrations measured in the circulation of PXE patients 
(Vanakker et al, 2010) were not associated by an impairment of their blood coagulation system, 
indicating that the vitamin can reach the liver to be metabolized and used for the activation of 
coagulation factors, while it seems to be extruded or transported less efficiently from hepatocytes to 
the periphery (Borst et al., 2008; Brampton et al., 2011), thus affecting connective tissues. In this 
scenario, it has been suggested that vitamin K supplementation might be capable of restoring MGP 
carboxylation and to inhibit ectopic calcifications (Borst et al, 2008). However, recent studies in the 
PXE animal model (abcc6-/- mice) demonstrated that vitamin K supplementation does not 
counteract the mineralization of soft connective tissues (Brampton  et al., 2011; Gorgels et al, 2011; 
Jiang et al, 2011). Key question is whether PXE fibroblasts are able to utilize vitamin K and to 
restore an adequate MGP carboxylation.  
Since both vitamin K1 and K2 can be used as diet supplements (Cranenburg et al, 2007), the aim of 
the present study was to investigate the effects of vitamin K1 (phylloquinone) and vitamin K2 
(menaquinone-4, MK-4) supplementation on control and on PXE dermal fibroblasts, for a better 
understanding of the role of vitamin K-dependent carboxylation of MGP in PXE pathogenesis and 
in the negative outcome of treatments performed so far in the animal model.  
Moreover, since ectopic calcifications are mainly due to calcium phosphate precipitation, we also 
investigated the possibility to interfere with the mineralization process, by modulating alkaline 
phosphatase (ALP) activity, that promotes hydroxyapatite formation by acting on phosphate-donor 
substrates (Orimo, 2010).  
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Results and Discussion   
 
Assessment of blood parameters related to ectopic calcification 
Calcification is subject to regulation on many different levels, both systemic and local. We have 
investigated in 79 PXE patients the levels of a number of circulating parameters known to be related 
to the development of ectopic calcifications and compared the values with reference values in 
control individuals (Table 1).  
Calcemia and phosphatemia are always within normal range, thus confirming that in PXE: 1) 
deregulation of circulating levels of calcium and phosphate are only rarely observed, possibly as an 
additional unrelated clinical complication (Mallette and Mechanick, 1987); 2) ectopic calcification 
does not take place through the “calcification paradox” (Krueger et al., 2009), i.e. by increased 
circulating levels of calcium and phosphate due to decreased bone mineral density, as confirmed by 
the absence of altered bone metabolism in all patients investigated so far.  
Similarly, activity of serum ALP activity never appeared up-regulated in patients (Table 1), which 
is consistent with the absence of a generalized calcification process. Since collagen fibrils never 
undergo mineralization in PXE and normal as well as calcified elastic fibers coexist within the same 
tissues, it is conceivable to hypothesize a local deregulation of  pro- and anti-calcifyng factors. 
Finally, we have measured the levels of dp-ucMGP and dp-cMGP (Table 1); no significant 
difference were observed between control and PXE samples. 
Although it cannot be excluded that altered, still unknown serum factor/s could be present in the 
circulation of patients, control subjects and PXE patients, or PXE patients with different 
extent/severity of clinical manifestations cannot be discriminated on the basis of these parameters.  
 
Vitamin K uptake by dermal fibroblasts and cell viability  
Few data are available in the literature concerning the ability of fibroblasts to respond to in vitro 
vitamin K treatments (Canfield et al., 1987; Ross et al., 1991) and no data are available on human 
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dermal fbroblasts in primary culture. In addition, the demonstration that vitamin K supplementation 
does not counteract soft connective tissue mineralization, in the PXE animal model (Brampton et 
al., 2011; Gorgels et al., 2011; Jiang et al., 2011;), poses the question whether PXE fibroblasts are 
unable to utilize the vitamin (Boraldi et al., 2009). 
Despite a certain heterogeneity observed between cells from different individuals, a similar dose-
dependent vitamin K uptake is clearly detectable in both control and PXE fibroblasts (figure 1), 
although, the uptake of phylloquinone (figure 1a) is higher than that of menaquinone (figure 1b) at 
comparable doses in the culture medium. These data clearly demonstrate that fibroblasts can take up 
and accumulate vitamin K and that this trait is not affected by the pathologic phenotype (figure 1).  
In the light of these results, further experiments were performed with the lowest (0.1µM) and the 
highest (100µM) vitamin concentrations. The highest concentration was chosen to guarantee the 
possibility to quantify the effects of vitamin supplementation, even in short-term cultures (48h); the 
lowest concentration was chosen to follow the intracellular uptake and to look for eventual 
cumulative effects in long-term cultures (≥ 20 days). 
Evaluation of cell viability demonstrates that, in standard culture conditions (i.e. DMEM), both 
vitamins, even at very high concentrations and for long-term cultures (>20 days), never appeared to 
inhibit cell growth or to induce cell death (data not shown), as demonstrated for K2 in different 
tumor cell lines (Ogawa et al., 2007), where the pro-apoptotic effect of the vitamin could be the 
consequence of metabolic pathways associated to the neoplastic phenotype. Consistently, vitamin K 
has been safely used in many long-term in vivo treatments (Iwamoto et al., 2009), supporting the 
feasibility to use these dietary compounds for therapeutic strategies (McCann and Ames 2009).  
As far as the effects of vitamin K on the cellular redox balance, in contrast to the menadione-
induced generation of reactive oxygen species (ROS) (Loor et al., 2010), vitamin K1 and K2 
supplementation never induced oxidative stress. In particular, vitamin K1 never modified the 
intracellular accumulation of O2•- and H2O2 (data not shown), whereas vitamin K2, at the highest 
dose (100 µM) significantly (p ≤ 0.05) reduced the level of O2•- in both control and PXE fibroblasts. 
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In particular, values, measured as fluorescence arbitrary units, were 0.70±0.07 in controls; 
0.55±0.07 in controls+K2; 1.11±0.06 in PXE and 0.66±0.07 in PXE+K2, in agreement with 
previous observations that menaquinone can act as positive modulator of oxidative stress (Li et al., 
2009).  
 
Endoplasmic reticulum-proteins involved in vitamin K cycle 
To exclude that vitamin K supplementation may be associated to ER-stress, having a negative effect 
on vitamin K-dependent carboxylation and favoring the calcification process (Liberman et al., 
2001), we have investigated the expression of GRP-78, a well known marker of ER-stress (Zhang 
and Kaufman, 2006). Data indicate that GRP-78 expression (figure 2a and b) was very similar in 
control and in PXE fibroblasts and remained unmodified after treatments, clearly demonstrating that 
intracellular accumulation of vitamin K is not associated to ER-stress. 
Moreover, since PXE fibroblasts are characterized by chronic oxidative stress (Pasquali Ronchetti 
et al., 2006) and the redox environment within the ER is known to affect the carboxylation process, 
we investigated if vitamin K supplementation can modify the expression of other molecules that, in 
the ER, are involved in vitamin K cycle, as PDI (figure 2a and c) and CALU (figure 2a and d), that 
are respectively down- and up-regulated in PXE (Boraldi et al., 2009). Both vitamins K1 and K2, 
independently from concentration, similarly down-regulate the expression of CALU in all cell 
strains (figure 2a and d), whereas changes were negligible in the case of PDI (figure 2a and c), 
indicating that the effect of vitamin K supplementation on the expression of ER-proteins involved 
in vitamin K cycle was not pathway-specfic.  
 
Protein carboxylation and MGP expression 
Gla-residues were evaluated on total protein extracts, as markers of protein carboxylation. Data 
reveal that control and PXE fibroblasts have a comparable number of bands of similar intensity 
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(figure 3a and 3b), suggesting that the whole carboxylation process in PXE fibroblasts is equivalent 
to that of controls. 
Possibly due to the low sensibility of this parameter, low doses of vitamin K1 and K2 are not 
associated to significant differences in total densitometry of bands. By contrast, high doses of 
vitamin K1 and K2 markedly up-regulated band’s intensity in all cell strains, indicating that the 
carboxylation process is similarly modulated in both control and PXE fibroblasts (figure 3a and b).  
Moreover, by comparing data on the intracellular vitamin K content (figure 1) and the amount of 
carboxylated proteins (figure 3a and b), it appears that vitamin K2, although present inside cells at 
lower levels compared to phylloquinone, has a similar effect on the carboxylation process, in 
agreement with previous findings that menaquinone is more efficient than phylloquinone in extra-
hepatic tissues (Wallin et al., 2008). 
On the basis of the positive effects of vitamin K on the carboxylation process, we have looked for 
changes in MGP expression and maturation. Unexpectedly, vitamin K supplementation never 
induced a significant MGP up-regulation. In particular, at high doses, vitamin K1 significantly 
reduced MGP protein expression in PXE fibroblasts (figure 3f), whereas both in control and PXE 
fibroblasts vitamin K2 down-regulated MGP, at gene and protein levels (figure 3 c-f). Moreover, 
treatment with vitamin K2, at all doses, did not increase cMGP (figure 3g and h), whereas vitamin 
K1 appeared to up-regulate cMGP, although only in control fibroblasts (figure 3g).  
All these data are in agreement and help understand the observations by Brampton and coworkers 
(Brampton et al., 2011) that MGP remained undercarboxylated in the muzzle tissue of abcc6 -/- 
mice despite the increase in circulating levels of vitamin-K. In particular, results from the present 
study demonstrate that in PXE, in a general setting of vitamin K availability and adequate 
carboxylation process, MGP is not sufficiently carboxylated. It could be suggested that the defect 
may specifically involve MGP and that the extent of gamma-carboxylation could be related not only 
on the bioavailability of cofactors, but also on the binding affinity between proteins and gamma-
glutamylcarboxylase (Berkner, 2008). 
 8 
Surprisingly, in the absence of any effect on cell counts and/or cell viability, K2 negatively 
modulated MGP expression, apparently in contradiction with the statement that in vivo vitamin K2 
is specifically active in modulating the calcification process (Spronk et al, 2003; Beulens et al, 
2009), although, in most cases, positive effects, observed either in vitro and/or in vivo, have to be 
related to supplementation with menaquinones with longer chains or by the simultaneous presence 
of other dietary components and/or to healthier life style behavior (Rees et al., 2010). Moreover, it 
cannot be excluded that these results could be due to a different behavior of fibroblasts compared to 
smooth muscle cells, or, as it has been described in other cell types (Goritz et al., 2007; Mertsch et 
al., 2009), to the association of low MGP expression with low proliferation/migration of cells, as an 
additional effect of vitamin K2 supplementation   
 
Alkaline phosphatase activity 
ALP is considered a marker of the calcification since it degrades phosphate donors, releasing 
inorganic phosphate and decreasing the concentration of inhibitors such as pyrophosphate (Orimo 
2010). Evaluation of ALP activity in fibroblasts cultured in standard medium clearly shows that 
values are elevated in PXE fibroblasts and remain unmodified by vitamin K, whereas a significant 
inhibition can be measured after levamisole supplementation (Table 2).  
 
Calcification assay 
Independent from their ability to induce mineralization in vivo, cells in normal culture conditions 
are not able to mineralize, due to the presence in the culture medium of bovine serum factors, as 
fetuin, that acts as a potent calcification inhibitor. Therefore, in order to induce the calcification 
process in vitro, a complex environment is necessary such as that provided by addition of β-
glycerophosphate (a source of organic phosphate), dexamethasone (a glucorticoid that up- and 
down-regulates osteogenic or inhibitor molecules, respectively) and ascorbic acid (an essential co-
factor for collagen synthesis as a fundamental substrate for mineral deposition) (Buranasinsup et al., 
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2006). Starting from 10 days of culture in this specific calcifying medium, areas of mineralization 
can be visualized in all fibroblast strains, progressively increasing with time (figure 4). The 
heterogeneous distribution of calcifications on the cell surface indicates that this phenomenon is not 
due to a passive diffuse precipitation, but it is the result of specific cell-dependent processes. 
Treatment with levamisole inhibited the mineralization process, whereas vitamin K 
supplementation was always uneffective in all cell strains (figure 4). The observation that 
menaquinone, at the lowest concentration, actually favored the accumulation of mineral deposits, 
could be due to the fact that, as observed in osteoblastic cell lines, vitamin K2, differently from 
vitamin K1, has a transcriptionally regulatory function on extracellular matrix genes (Koshihara et 
al., 2003; Ichikawa et al., 2006), consistent with the use the vitamin K2 as potential anti-
osteoporotic agent (Iwamoto et al., 2009.  
Evaluation of ALP activity (figure 4) in these long-term culture conditions indicates that enzyme 
activity: 1) is higher in PXE compared to control fibroblasts; 2) is not significantly modified by 
vitamin K supplementation, 3) is influenced by the extracellular environment, due to the 
progressive accumulation of matrix molecules, as in the case of cells cultured in CM. To be noted 
that CM favors extracellular matrix deposition (figure 1 Supplementary material) leading to a thick 
layer of matrix covering and partially embedding the cell monolayer and for this reason at 30 days 
the matrix is so dense that it negatively interferes with protein solubilization unabling appropriate 
ALP activity determination. Surprisingly, for long periods of culture in CM (≥ 20 days), the highest 
dose of vitamin K2 was associated to changes in cellular morphology leading to areas of cell 
detachment in both control and PXE fibroblasts (figure 4). However. it is worth mentioning that no 
toxic effects were noticed on cells grown in standard medium supplemented with vitamin K2 (at all 
doses and for long times of culture) (Figure 2 Supplementary material), nor in CM alone or in the 
presence of phylloquinone (data not shown), It could be therefore hypothesized that menaquinone 
may interact with some CM component(s), thus negatively interfering with cell viability.   
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Conclusions  
Despite the well known limits provided by the simplifications usually associated with in vitro 
models, never the less studies on cultured human dermal fibroblasts isolated from healthy subjects 
as well as from PXE patients, maintaining in vitro several characteristics related to their pathologic 
phenoptype (Quaglino et al., 2011), allow direct investigation of the response of human peripheral 
mesenchymal cells, avoiding interferences due to dietary absorption properties and/or transport 
capabilities in the circulation. From in vivo studies on the PXE animal model it was suggested that, 
due to still elusive mechanisms, availability of vitamin K is not a limiting factor in the pathology of 
PXE and/or that vitamin K-dependent inhibition of calcification may not be preponderant in the 
development of the disease (Brampton et al., 2011). Present results demonstrate that vitamin K1 and 
K2 can be taken up and accumulated at similar levels by control and PXE fibroblasts, that the 
carboxylation process can be consequently similarly up-regulated in both cell strains, although 
MGP cannot be adequately carboxylated, even at increased levels of vitamin K. It can be therefore 
excluded that PXE fibroblasts are not capable to utilize the vitamin, thus suggesting that altered 
MGP characteristics/properties could at least contribute to defective carboxylation.  
Within this context and given its peculiar matrix localization on the elastic component (Gheduzzi et 
al., 2007), MGP may contribute to the selective mineral deposition on elastic fibers. Moreover, the 
observation that in an in vitro calcification model, both vitamin K1 and K2 are ineffective in 
inhibiting the mineralization process, also in control fibroblasts, i.e. in cells that do not exhibit 
reduced cMGP, may underline the importance and the complexity of the extracellular environment 
in mineral deposit formation and in regulating cell behavior. In the development of ectopic 
calcifications, not a single component is prevalent or unique, but the unbalance ratio between many 
different factors locally controlling calcium and phosphate homeostasis, as well as the 
characteristics of the extracellular matrix, may be decisive in the question whether a tissue will start 
to calcify. Therefore, beside vitamin-K dependent molecules, other factors, including the 
upregulation of ALP, must be taken into account for future therapeutic options  
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Materials and Methods  
 
More detailed information  on materials and methods is available at Supplementary Materials and 
Methods. 
 
Patients 
PXE patients were diagnosed on the basis of clinical manifestations, histopathological findings and 
identification of ABCC6 gene mutations (Gheduzzi et al., 2004). 
Laboratory parameters (calcemia, phosphatemia, alkaline phosphatase activity) were measured in 
the plasma of 79 patients according to the Clinical Pathology Laboratory routine procedures. 
Plasma levels of dp-ucMGP and of dp-cMGP were measured in the same patients by sandwich 
ELISAs techniques already developed at VitaK BV (Maastricht, The Netherlands) (Cranenburg et 
al, 2010). The different sensitivity of the two antibodies does not allow a direct comparison of the 
amount of two forms of MGP and evaluations have to be done between controls and PXE within the 
same parameter. 
 
Cells and treatments 
Human dermal fibroblast cultures were obtained in accordance with the Declaration of Helsinki 
protocol and the guidelines of the ethical committee of the Modena University Faculty of Medicine, 
after written informed consent from 5 clinically healthy females, (38 ±7 years) which did not 
exhibit any sign of genetic, metabolic or connective tissue disorders and from 6 PXE patients (40 
±10 years).  
Confluent fibroblasts were treated with 0.1, 1, 10 and 100µM phylloquinone (vitamin-K1, Sigma, 
St Louis-MO) or menaquinone (MK-4) (vitamin-K2, Sigma) or with 100µM levamisole (Sigma). 
Cells grown in the presence of DMF (Sigma) alone were used as control of treatments.  
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Unless otherwise specified, cells from each individual were kept separate during all experiments. 
Fibroblast’s morphology was evaluated by phase-contrast microscopy and cell viability was 
assessed by cell count. 
 
High-performance liquid chromatography 
Confluent fibroblasts were treated with vitamins for 48h, washed in buffer, trypsinized and 
centrifuged. Cell pellets were stored at -80°C and sent to VitaK (Maastricht-The Netherlands) for 
measuring, on cell extracts, vitamin K1 and K2 intracellular concentrations by HPLC, using a 
reversed-phase column with online zinc reduction and fluorescence detection (Schurgers et al., 
2007).  
 
Flow cytometry  
Intracellular levels of O2- and H2O2 were estimated by FACS after incubation of fibroblasts with 
1µM DH2 or with 2µM H2DCF-DA (Molecular Probes, Eugene-OR), respectively (Boraldi et al., 
2009). Experiments were performed three times in duplicate. 
 
Protein extraction  and Western blot  
Cells were homogenized in RIPA buffer with protease inhibitors (Sigma), centrifuged and 
supernatants collected and stored at −80°C until analysis. After measurement of protein 
concentration (Bradford, 1976) proteins were separated by 1D or 2D-PAGE (Gheduzzi et al., 2007; 
Boraldi et al., 2009). After separation, proteins were transferred to nitrocellulose and incubated with 
anti-GRP78, anti-PDI (Abcam, Cambridge-UK); anti-CALU, anti-MGP (Santa Cruz 
Biotechnology, Santa Cruz-CA); anti-γ-Gla-residues (American Diagnostica, Stamford-CT); anti-
cMGP (Vascular Products, Maastricht-The Netherlands) and thereafter with appropriate horseradish 
peroxidase (HRP)-conjugated secondary antibodies (Abcam).  
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1D-PAGE experiments were performed at least two times with all different cell lines.In the case of 
cMGP, due to the low abundance of the protein, analyses by 2D-PAGE were carried out on proteins 
extracted from a pool of fibroblasts from 6 patients and from 5 controls and data are expressed as 
mean values ± SD of replicates. 
 
Quantitative real-time RT-PCR  
Total RNA was isolated from cells using the RNeasy Protect cells Mini kit (Qiagen, Milano-Italy) 
and reversely transcribed using Superscript III (Invitrogen, Monza-Italy) and Oligo dT18 primers 
(Invitrogen). cDNAs were amplified on a iCycler (BioRad, Hercules-CA) using SYBR® 
GreenERTMqPCR SuperMix (Invitrogen). MGP gene expression in each sample was normalized 
against CLK2 and quantified (Pfaffl, 2001). Experiments were performed two times in triplicate. 
 
Alkaline phosphatase activity 
ALP activity was measured spectrophotometrically at 405 nm on control and PXE fibroblasts and 
values of optical density were related to cellular protein concentration (Bradford, 1976).. 
Experiments were performed three times in triplicate. 
 
In vitro calcification and Von Kossa staining 
Fibroblasts were routinely cultured in 6-well plates (BD-Falcon, Franklin Lakes-NJ) up to 
confluence, then the standard medium (DMEM + 10% FBS, Gibco, Monza-Italy) was replaced by 
the same medium or by the calcified medium (i.e. standard medium plus 10mM β-
glycerophosphate, 50µg/ml ascorbic acid and 10 nM dexamethasone, Sigma) (Buranasinsup et al., 
2006). Vitamin K1 and K2 (0.1µM and 100µM) and levamisole (100µM) were added to each type 
of culture media. After 10-20-30 days, cells were stained with the Von Kossa method and areas of 
mineralization quantified on digital images. Experiments were performed three times. 
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Data analysis 
Data are expressed as mean values ± SD of all measurements and compared by Mann Whitney or 
by Anova test using GraphPad software (San Diego-CA). 
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Table 1: Plasma levels of  selected ectopic calcification-related parameters 
 
 
 Controls* PXE 
Calcium 
mg/dL 8.6 -10.3 9.53 ± 0.4 
Phosphate 
mg/dL 2.4 - 4.8 3.4 ± 0.6 
ALP activity 
U/L 40 -129 66.5 ± 37.7 
dp-ucMGP 
pmol/L 426 ± 235 300 ± 221 
dp-cMGP 
pmol/L 1865 ± 597 1169 ± 603 
dp-ucMGP/dp-cMGP 0.23 ± 0.09 0.24 ± 0.12 
 
*  Normal reference range/values 
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Table 2: Alkaline phosphatase activity in control and PXE fibroblasts treated for 48 hours 
after confluence.  
 
 
 
 DMEM DMEM + Vitamin K1  
DMEM 
+ Vitamin K2 
DMEM 
+ Levamisole 
  0.1 µM 100 µM 0.1 µM 100 µM 100µM 
Control § 1 ± 0.2 0.9 ± 0,2 1.2 ± 0.05 1 ± 0.1 1 ±0.09 0.2 ± 0.09** 
PXE § 1.5 ± 0.3* 1.3 ± 0,1 1.1 ± 0.2 1.1 ± 0.3 1.1 ± 0.2 0.1 ± 0.07** 
 
§ Enzyme activity is measured in confluent fibroblasts. Values are normalized to those of 
control fibroblasts cultured in DMEM, set as one-fold, and expressed as mean values ± SD.  
 
*  p ≤ 0.05  PXE vs Control fibroblasts 
** p ≤ 0.01  Levamisole treatment vs DMEM  
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Figure Legends 
 
Figure 1.  
Amount of vitamin K1 and K2 taken up by control and PXE dermal fibroblasts. 
Intracellular determinations of phylloquinone (vitamin K1, a) and menaquinone (vitamin K2, b) 
content in fibroblasts from control and PXE patients grown in vitro for 48h after confluence in the 
presence of the vitamin (0.1, 1, 10 and 100 µM). As controls, cells were cultured in the presence of 
comparable amounts of DMF without vitamin K. A dose-dependent uptake can be measured in both 
control and PXE cells (a linear regression analysis is shown in small graphs in the upper-left side of 
each panel). 
 
Figure 2.  
Effect of vitamin K1 and K2 on the expression of ER-related proteins in control and in PXE 
fibroblasts. 
Expression of GRP-78 (b), PDI (c) and CALU (d) evaluated by Western blot on control (left panels) 
and PXE (right panels) fibroblasts, cultured for 48 hours after confluence with vitamin K1 or K2 ( 
0.1 and 100 µM). Data in histograms are expressed as mean values ± SD. Representative WBs of 
control (lines 1,3,5,7,9) and PXE (lines 2,4,6,8,10) fibroblasts in the presence of DMF (lines 1 and 
2), 0.1µM K1 (lines 3 and 4), 100µM K1 (lines 5 and 6), 0.1µM K2 (lines 7 and 8), 100µM K2 
(lines 9 and 10) are shown at the top of the figure (a).  
* p<0.05 treatment vs DMF (dotted line set at 1). 
 
Figure 3.  
Effect of vitamin K1 and K2 on carboxylated proteins in control and in PXE fibroblasts. 
Determination of Gla-residues (a,b) and MGP expression (c-h) in control and PXE confluent 
fibroblasts grown for 48h in DMEM + 10% FBS (DM) supplemented with the solvent alone (DMF) 
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or with vitamin K1 and K2 (0.1 and 100 µM). Representative WBs for Gla-residues are shown in 
panels a and b, whereas values on top of each line represent densitometric analyses of all bands 
obtained in duplicate using all cell strains. MGP expression was analyzed by RT-PCR (c,d) and WB 
(e,f), whereas cMGP was evaluated by 2D-WB (g,h). Data are expressed as mean values ± SD.  
*p<0.05 treatment vs DMF (dotted line set at 1); § p<0.05 PXE vs control fibroblasts within the 
same experimental condition. 
 
Figure 4.  
In vitro calcification assay.  
Control and PXE fibroblasts were cultured in standard medium (DMEM) or in calcified medium 
(CM) supplemented with vitamin K1, K2 or levamisole.  Calcificaton is visualized at 30 days by 
light microscopy as dark precipitates (upper panels). In the lower part of the figure, the extent of 
mineralization (number of virtual meshes containing von Kossa positive precipitates in each culture 
plate) is reported at different time points, together with  ALP activity (fold changes normalized to 
control fibroblasts cultured for 10 days in CM plus DMF). . Data are expressed as mean values ± 
SD.   
#occurrence of cellular morphological alterations;  * p<0.05  PXE vs Control 
n.d. (not determined) due to areas of cell death or to thickness and partial insolubility of the 
deposited extracellular matrix , in the case of mineralization and ALP activity, respectively. 
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SUPPLEMENTARY MATERIAL 
 
Materials and Methods 
 
Patients 
PXE patients were diagnosed on the basis of skin and eye clinical alterations further confirmed by 
light and electron microscopy on skin samples and by identification of ABCC6 gene mutations 
according to procedures already described (Gheduzzi et al, 2004). 
Blood was taken from 79 PXE patients by venipuncture, collected in appropriate tubes and stored 
for 1 hr at room temperature. Serum was collected after centrifugation at 3000xg for 10 min and  
aliquots (0.5 mL) frozen and stored at -80°C until use. For plasma, blood collected into Na-citrate 
containing tubes was centrifuged at 3500 × g for 10 min at 4°C. Aliquots of plasma-citrate were 
stored at −85°C until use.  
Laboratory parameters (calcemia, phosphatemia, alkaline phosphatase activity) were measured 
according to the routine procedures standardized in the Clinical Pathology Laboratory accredited by 
Regione Emilia Romagna for analytical activities and certified to UNI EN ISO 9001-2008. As 
controls, normal laboratory reference values were used.  
Age and gender of patients were recorded in order to properly analyze and compare data. 
 
Circulating MGP determinations 
Plasma levels of desphospho-carboxylated MGP (dp-cMGP) or desphospho uncarboxylated MGP 
(dp-ucMGP) were measured by sandwich ELISAs techniques already developed at VitaK-BV 
(Maastricht, The Netherlands) (Cranenburg et al, 2010). In brief, microtiter plates were coated with  
monoclonal antibodies against the non-phosphorylated MGP 3-15 aa sequence. After blocking, 
either patient plasma or standards were transferred to the plates. The standards were synthetic 
peptides based on the non-phosphorylated 3–15 aa sequence and either the non-carboxylated 35–54 
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aa. sequence or carboxylated 35–54 aa. sequence, linked with a hydrophilic spacer (Pepscan, 
Lelystad, The Netherlands). After incubation and washing, the standards or the samples were 
detected using biotinylated monoclonal antibodies against the uncarbiylated or carboxylated 35-54 
aa. sequence in human MGP, incubated with streptatavidin-peroxide with 
3,3’,5,5’tetramethylbenzidine. 
 
Cells and treatments 
Human dermal fibroblast cultures were obtained in accordance with the Declaration of Helsinki 
protocol and the guidelines of the ethical committee of the Modena University Faculty of Medicine, 
after written informed consent from 5 clinically healthy females, (38 ±7 years) which did not 
exhibit any sign of genetic, metabolic or connective tissue disorders and from 6 PXE patients (40 
±10 years).  
Confluent fibroblasts were treated for 48h with phylloquinone (vitamin-K1, C31H46O2, 450.7Da, 
Sigma, St. Louis, MO) or with menaquinone (MK-4) (vitamin-K2, C31H40O2, 444.65Da, Sigma) at 
the concentration of 0.1, 1, 10 and 100µM. Due to their water insolubility, vitamins were dissolved 
in dimethylformamide (DMF, Sigma). Cells grown in the presence of DMF alone were used as 
control of treatments. Unless otherwise specified, cells from each individual were kept separate 
during all experiments. 
Treatment with ALP inhibitors was performed with 100µM levamisole (Sigma) on cells at 
confluence.  
Fibroblast’s morphology was evaluated by phase-contrast microscopy and cell viability was 
assessed by cell count. 
 
High-performance liquid chromatography (HPLC) 
Vitamin K1 and K2 intracellular concentrations were measured by HPLC of cell extracts. Briefly, 
confluent fibroblasts were treated with vitamins for 48h, washed in buffer, trypsinized and 
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centrifuged. Cell pellets were stored at -80°C and sent to VitaK (Maastricht, The Netherlands) for 
analysis. After thawing, cell pellets were taken up in 500µL of distilled water, sonicated for 15sec at 
12µm and supplemented with internal standard, followed by heating at 70oC for 30min and shaking 
vigorously for 5min. After cooling, 2.5mL of chloroform and 2.5mL of methanol were added 
followed by vigorous shaking and centrifugation for 10min at 1500g. The lower layer was 
transferred to a glass tube and organic solvents were evaporated until dryness under a stream of 
nitrogen at 50oC. The residue was taken up in 4 mL of n-hexane and vitamin K was eluted with 6 
mL of 3% (v/v) diethyl ether in n-hexane, collected and organic solvents were removed by 
evaporation under a stream of nitrogen at 50°C. The residue was dissolved in 80 µL of isopropanol 
and analyzed by HPLC using a reversed-phase column with online zinc reduction and fluorescence 
detection. Vitamin K1-25 (a synthetic form of vitamin K1 containing 5 isoprenoid residues) was 
used as internal standard (Schurgers et al., 2007). 
 
Flow cytometry  
For each measurement, cells were incubated with appropriate stains, and analyzed on an EPICS XL 
flow cytometer (Coulter, Milan, Italy) (Boraldi et al, 2009). Ten thousand events were collected and 
evaluated for each cell type using a WINMDI 2.8 program. Experiments were performed three 
times in duplicate. 
Superoxide anions (O2-) detection 
Intracellular levels of O2- were estimated by incubating fibroblasts with 1 µM dihydroethidium 
probe (DH2) (Molecular Probes, Eugene, OR) for 60 minutes at 37 °C . Fluorescence was measured 
at the emission wavelength of 575 nm. 
Hydrogen peroxide (H2O2) detection 
Trypsinized cells, resuspended in PBS, were stained with H2DCF-DA (Molecular Probes) at the 
final concentration of 2µM for 30 min at 37°C. Fluorescence was measured at the emission 
wavelength of 520 nm.  
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Protein extracts and Western blot 
Cells were homogenized in RIPA buffer with protease inhibitors (Sigma), centrifuged and 
supernatants collected and stored at −80°C until analysis. After measurement of protein 
concentration (Bradford, 1976), 30µg of proteins/lane were loaded on 10-lane 1-DE 10% 
polyacrylamide gel, under reducing conditions (Boraldi et al, 2009). In the case of cMGP, proteins 
were extracted in 8 M urea, 2% CHAPS, 65mM dithioerythritol, 2% pH 3–10 ampholyte (GE-
Healthcare, Chalfont St. Giles, UK) with trace of bromophenol blue. After measuring protein 
concentration (Bradford, 1976), 2D gel electrophoresis was performed (Boraldi et al, 2009). 
After separation in 1D or 2D-PAGE, proteins were transferred to nitrocellulose (Gheduzzi et al, 
2007; Boraldi et al, 2009) and incubated with the following primary antibodies: anti-glucose-
regulated endoplasmic reticulum stress response protein-78 (GRP78) (Abcam, Cambridge, UK, 
diluted 1:1000); anti-calumenin (CALU) (Santa Cruz Biotechnology, Santa Cruz, CA, diluted 
1:100); anti-protein disulfide isomerase (PDI) (Abcam, diluted 1:2000); anti-γ-carboxyglutamyl 
(Gla) residues (American Diagnostica, Stamford, CT, diluted 1:200); anti-matrix Gla protein (MGP) 
(Santa Cruz Biotechnology, 1:200 diluted) and anti-γ-carboxylated-MGP (cMGP) (Vascular 
Products, Maastricht, The Netherlands, diluted 1:5000). After incubation with appropriate 
horseradish peroxidase (HRP)-conjugated secondary antibodies (Abcam, diluted 1:5000), Western 
blots (WB) were visualized using Super Signal West Pico (Pierce, Rockford, IL). Densitometry of 
protein bands was performed using the ImageQuant TL v2005 software (GE-Healthcare).  
1D-PAGE experiments were performed at least two times with all different cell lines, whereas in 
the case of cMGP, due to the low abundance of the protein, analyses by 2D-PAGE were carried out 
on proteins extracted from a pool of fibroblasts from 6 patients and from 5 controls. 
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Quantitative real-time RT-PCR  
Total RNA was isolated from cells using the RNeasy Protect cells Mini kit (Qiagen, Milano, Italy), 
3µg of total RNA were reverse transcribed using Superscript III (Invitrogen Life Technologies, 
Monza, Italy) and Oligo dT18 primers (Invitrogen Life Technologies) and cDNAs were amplified on 
a iCycler (BioRad, Hercules, CA) using SYBR® GreenERTMqPCR SuperMix (Invitrogen Life 
Technologies), according to manufacturer’s instructions. Primers were designed using the Universal 
ProbeLibrary (www.universalprobelibrary.com) and synthesized by Invitrogen: MGP (5’-
CCCTCAGCAGAGATGGAGAG-3’ and 3’-GCTTCCCTATTGAGCTCGTG-5’) and CLK2 (5’-
GCACCATAGCACCATTGTC-3’ and 3’-GCACCATAGCACCATTGTC-5’). Efficiency of 
primers was 96.5% and 98.75%, respectively. Thermal cycling parameters were set to 50°C for 
2min, 95°C for 3min, 45 cycles of 95°C for 30s, an annealing temperature of 60°C for 30s and 72°C 
for 30s, followed by melting curve analysis with a temperature ranging from 95 to 55°C. Gene 
expression in each sample was normalized against the housekeeping gene (CDC-like kinase, CLK2) 
and quantified using the Pfaffl method (Pfaffl, 2001). Analyses were carried out two times in 
triplicate. 
 
Alkaline phosphatase activity 
Fibroblasts were detached by enzymatic treatment and washed three times with PBS. Cells were 
lysed by appropriate buffer containing 0.1% Triton X-100. Cell lysate (20µL) was mixed with 
100µL Tris-glycine buffer pH 10.3 (50mM Tris-HCl, 100mM glycine and 2mM MgCl2) and 100 
µL of p-nitrophenyl phosphate (Sigma). The reaction mix was incubated at 37°C for 30 min and the 
reaction stopped by adding 50µl of 3M NaOH. Absorbance was read at 405 nm in a microplate 
reader. Enzymatic activity was normalized to total protein concentration using bovine serum 
albumin as a standard for the Bradford protein detection method (Bradford, 1976).  
Control samples were set as 1. Experiments were performed at least three times in triplicate. 
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In vitro calcification and Von Kossa staining 
Fibroblasts were routinely cultured in 6-well plates (BD-Falcon, Franklin Lakes, NJ) up to 
confluence, then the standard medium (DMEM + 10% FBS, Gibco, Monza, Italy) was replaced by 
the same medium with or without vitamin K1 and K2 (0.1µM and 100µM) or levamisole (100µM), 
or by the calcified medium (i.e. standard medium plus 10mM β-glycerophosphate, 50µg/mL 
ascorbic acid and 10 nM dexamethasone, Sigma) (Buranasinsup et al, 2006) with or without vitamin 
K1 and K2 or levamisole. Media were changed three times a week. After 10-20-30 days, cells were 
stained with the Von Kossa method (fixation in 3.5% formaldehyde, washes and staining with 5% 
silver nitrate for 30 minutes under a UV lamp). Plates were photographed and digital images 
overlapped with a 100 mesh virtual grid. Areas of calcification were quantified as the number of 
meshes containing von Kossa positive precipitates in each fibroblast cell culture plate and data 
expressed as mean values ± SD. Experiments were performed three times. 
 
Data analysis 
Data are expressed as mean values ± SD of all measurements and compared by Mann Whitney or 
by Anova test with significance at p<0.05. Statistical data were obtained using GraphPad software 
(San Diego,CA). 
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Figure 1S: Human dermal fibroblasts cultured for 30 days in DMEM (a) or in CM (b). Upon 
trypsinization cells cultured in DMEM are easily detached from the plastic surface, appearing as 
round translucent single floating cells. By contrast, cells cultured in CM (b), independently from 
mineral deposition, are covered and partially embedded in a dense layer of matrix molecules 
(ECM), whose synthesis is favored by the dexamethasone and the ascorbate present in CM. After 
treatment with trypsin, this layer is detached from the plate as a continuous sheet that cannot be 
homogenously solubilized by usual protein extraction procedures.   
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Figure 2S: Control fibroblasts observed at the inverted microscope. Vitamin K2 100µM-
supplementation does not affect cell morphology and viability when cells are cultured in standard 
medium (DMEM), whereas it leads to changes in cell morphology (20 days) and to cell death 
(30days) when the vitamin is added to the calcifying medium (CM). 
Similar results can be visualized also for PXE fibroblasts. 
 
 
 
